Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Inv. presentation
Employment agrmnt
Quarterly results
Acq. announced
Director departure

Cogent Biosciences, Inc. (UMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 2,170 options to buy @ $9.55, valued at $20.7k
10/03/2023 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 2,345 options to buy @ $9.55, valued at $22.4k
07/05/2023 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,884 options to buy @ $11.96, valued at $22.5k
07/05/2023 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,743 options to buy @ $11.96, valued at $20.8k
06/08/2023 4 Morris Arlene (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
06/08/2023 4 CAIN CHRISTOPHER W. (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
06/08/2023 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
06/08/2023 4 Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
06/08/2023 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
06/08/2023 4 Harwin Peter Evan (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 36,700 options to buy @ $11.7, valued at $429.4k
04/04/2023 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,900 options to buy @ $10.75, valued at $20.4k
01/04/2023 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,792 options to buy @ $11.07, valued at $19.8k
01/04/2023 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,862 options to buy @ $11.07, valued at $20.6k
10/04/2022 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,419 options to buy @ $14.33, valued at $20.3k
10/04/2022 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 1,474 options to buy @ $14.33, valued at $21.1k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 622 shares @ $7.395, valued at $4.6k
06/21/2022 4 Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Bought 1,200,000 shares @ $8.25, valued at $9.9M
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 2,753 options to buy @ $7.92, valued at $21.8k
04/05/2022 4 Ros Matthew (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 2,650 options to buy @ $7.92, valued at $21k
01/27/2022 4 Green John L. (CFO) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 225,000 options to buy @ $7.6, valued at $1.7M
01/27/2022 4 Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 250,000 options to buy @ $7.6, valued at $1.9M
01/27/2022 4 Kearns Evan (Chief Legal Officer) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 202,250 options to buy @ $7.6, valued at $1.5M
01/27/2022 4 Robinson John Edward (Chief Scientific Officer) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 250,000 options to buy @ $7.6, valued at $1.9M
01/27/2022 4 Robbins Andrew R (President and CEO) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 690,000 options to buy @ $7.6, valued at $5.2M
01/04/2022 4 Sachs Jessica (Chief Medical Officer) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 674 shares @ $6.817, valued at $4.6k
01/04/2022 4 Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns: Granted 2,329 options to buy @ $8.7, valued at $20.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy